These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33998054)

  • 1. Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.
    Machherndl-Spandl S; Jäger E; Barna A; Gurbisz M; Marschon R; Graf T; Graf E; Geissler C; Hoermann G; Nösslinger T; Pfeilstöcker M; Bettelheim P; Zach O; Weltermann A; Heibl S; Thaler J; Zebisch A; Sill H; Stauder R; Webersinke G; Kusec R; Ulsperger E; Schneeweiss B; Öhler L; Germing U; Valent P; Tüchler H; Geissler K
    Eur J Haematol; 2021 Aug; 107(2):265-274. PubMed ID: 33998054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.
    Geissler K; Jäger E; Barna A; Gurbisz M; Marschon R; Graf T; Graf E; Borjan B; Jilch R; Geissler C; Hoermann G; Esterbauer H; Schwarzinger I; Nösslinger T; Pfeilstöcker M; Tüchler H; Reisner R; Sliwa T; Keil F; Bettelheim P; Machherndl-Spandl S; Doleschal B; Zach O; Weltermann A; Heibl S; Thaler J; Zebisch A; Sill H; Stauder R; Webersinke G; Petzer A; Kusec R; Ulsperger E; Schneeweiss B; Berger J; Öhler L; Germing U; Sperr WR; Knöbl P; Jäger U; Valent P
    Wien Klin Wochenschr; 2019 Sep; 131(17-18):410-418. PubMed ID: 31321531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival.
    Geissler K; Jäger E; Barna A; Graf T; Graf E; Öhler L; Hoermann G; Valent P
    Eur J Haematol; 2021 May; 106(5):627-633. PubMed ID: 33432601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
    Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
    Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
    Pleyer L; Leisch M; Kourakli A; Padron E; Maciejewski JP; Xicoy Cirici B; Kaivers J; Ungerstedt J; Heibl S; Patiou P; Hunter AM; Mora E; Geissler K; Dimou M; Jimenez Lorenzo MJ; Melchardt T; Egle A; Viniou AN; Patel BJ; Arnan M; Valent P; Roubakis C; Bernal Del Castillo T; Galanopoulos A; Calabuig Muñoz M; Bonadies N; Medina de Almeida A; Cermak J; Jerez A; Montoro MJ; Cortés A; Avendaño Pita A; Lopez Andrade B; Hellstroem-Lindberg E; Germing U; Sekeres MA; List AF; Symeonidis A; Sanz GF; Larcher-Senn J; Greil R
    Lancet Haematol; 2021 Feb; 8(2):e135-e148. PubMed ID: 33513373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems in the classification of CMML--dysplastic versus proliferative type.
    Germing U; Gattermann N; Minning H; Heyll A; Aul C
    Leuk Res; 1998 Oct; 22(10):871-8. PubMed ID: 9766745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic Transformation in Mexican Population With Chronic Myelomonocytic Leukemia.
    Rivera Duarte A; Armengol Alonso A; Sandoval Cartagena E; Tuna Aguilar E
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):532-538. PubMed ID: 28842140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute transformation of chronic myelomonocytic leukaemia: a multivariate study of predictive factors.
    Ribera JM; Cervantes F; Reverter JC; Montserrat E; Rozman C
    Eur J Haematol; 1989 Mar; 42(3):284-8. PubMed ID: 2924891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study.
    Moreno Berggren D; Kjellander M; Backlund E; Engvall M; Garelius H; Lorenz F; Nilsson L; Rasmussen B; Lehmann S; Hellström-Lindberg E; Jädersten M; Ungerstedt J; Ejerblad E
    Br J Haematol; 2021 Feb; 192(3):474-483. PubMed ID: 32501529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
    Elena C; Gallì A; Such E; Meggendorfer M; Germing U; Rizzo E; Cervera J; Molteni E; Fasan A; Schuler E; Ambaglio I; Lopez-Pavia M; Zibellini S; Kuendgen A; Travaglino E; Sancho-Tello R; Catricalà S; Vicente AI; Haferlach T; Haferlach C; Sanz GF; Malcovati L; Cazzola M
    Blood; 2016 Sep; 128(10):1408-17. PubMed ID: 27385790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment in chronic myelomonocytic leukemia (CMML).
    Germing U; Kündgen A; Gattermann N
    Leuk Lymphoma; 2004 Jul; 45(7):1311-8. PubMed ID: 15359628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of Prognostication in Chronic Myelomonocytic Leukemia.
    Onida F
    Curr Hematol Malig Rep; 2017 Dec; 12(6):513-521. PubMed ID: 29064026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
    Onida F; Kantarjian HM; Smith TL; Ball G; Keating MJ; Estey EH; Glassman AB; Albitar M; Kwari MI; Beran M
    Blood; 2002 Feb; 99(3):840-9. PubMed ID: 11806985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia--distinct subgroups or two stages of the same disease?
    Voglová J; Chrobák L; Neuwirtová R; Malasková V; Straka L
    Leuk Res; 2001 Jun; 25(6):493-9. PubMed ID: 11337023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
    Gur HD; Loghavi S; Garcia-Manero G; Routbort M; Kanagal-Shamanna R; Quesada A; Khogeer H; Pierce S; Medeiros LJ; Kantarjian H; Khoury JD
    Am J Surg Pathol; 2018 Jun; 42(6):799-806. PubMed ID: 29596070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia.
    Lackner D; Geissler K
    Wien Med Wochenschr; 2023 Feb; 173(1-2):27-33. PubMed ID: 36414855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.
    Harrington AM; Schelling LA; Ordobazari A; Olteanu H; Hosking PR; Kroft SH
    Am J Clin Pathol; 2016 Aug; 146(2):170-81. PubMed ID: 27413139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
    van der Helm LH; Alhan C; Wijermans PW; van Marwijk Kooy M; Schaafsma R; Biemond BJ; Beeker A; Hoogendoorn M; van Rees BP; de Weerdt O; Wegman J; Libourel WJ; Luykx-de Bakker SA; Minnema MC; Brouwer RE; Croon-de Boer F; Eefting M; Jie KS; van de Loosdrecht AA; Koedam J; Veeger NJ; Vellenga E; Huls G
    Br J Haematol; 2011 Dec; 155(5):599-606. PubMed ID: 21981697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.